These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3238767)

  • 1. Observations on antibody levels associated with active and passive immunity to African horse sickness.
    Blackburn NK; Swanepoel R
    Trop Anim Health Prod; 1988 Nov; 20(4):203-10. PubMed ID: 3238767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive transfer and rate of decay of maternal antibody against African horse sickness virus in South African Thoroughbred foals.
    Crafford JE; Lourens CW; Gardner IA; Maclachlan NJ; Guthrie AJ
    Equine Vet J; 2013 Sep; 45(5):604-7. PubMed ID: 23294121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. African horse sickness in Zimbabwe: 1972 to 1981.
    Blackburn NK; Swanepoel R
    Trop Anim Health Prod; 1988 Aug; 20(3):169-76. PubMed ID: 3194977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines.
    Crafford JE; Lourens CW; Smit TK; Gardner IA; MacLachlan NJ; Guthrie AJ
    Vaccine; 2014 Jun; 32(29):3611-6. PubMed ID: 24814557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
    Maree S; Paweska JT
    J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
    Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
    Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral antibody response of 10 horses after vaccination against African horse sickness with an inactivated vaccine containing all 9 serotypes in one injection.
    Wernery U; Rodriguez M; Raghavan R; Syriac G; Miriam Thomas M S; Elizabeth SK; Federico Ronchi G; Muhammed R; Patteril NA; Joseph S
    Equine Vet J; 2021 Jul; 53(4):826-833. PubMed ID: 33011979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
    van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
    J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6.
    von Teichman BF; Dungu B; Smit TK
    Vaccine; 2010 Sep; 28(39):6505-17. PubMed ID: 20638456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
    van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
    Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of two adjuvant formulations of an inactivated African horse sickness vaccine in guinea-pigs and target animals.
    Ronchi GF; Ulisse S; Rossi E; Franchi P; Armillotta G; Capista S; Peccio A; Di Ventura M; Pini A
    Vet Ital; 2012; 48(1):55-76. PubMed ID: 22485003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response of horses to inactivated African horse sickness vaccines.
    Rodríguez M; Joseph S; Pfeffer M; Raghavan R; Wernery U
    BMC Vet Res; 2020 Sep; 16(1):322. PubMed ID: 32873300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivated and adjuvanted vaccine for the control of the African horse sickness virus serotype 9 infection: evaluation of efficacy in horses and guinea-pig model.
    Lelli R; Molini U; Ronchi GF; Rossi E; Franchi P; Ulisse S; Armillotta G; Capista S; Khaiseb S; Di Ventura M; Pini A
    Vet Ital; 2013; 49(1):89-98. PubMed ID: 23564590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A competitive ELISA for the detection of group-specific antibodies to African horse sickness virus.
    Hamblin C; Graham SD; Anderson EC; Crowther JR
    Epidemiol Infect; 1990 Apr; 104(2):303-12. PubMed ID: 2108871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on the efficacy of an inactivated African horse sickness serotype 4 vaccine.
    House JA; Lombard M; Dubourget P; House C; Mebus CA
    Vaccine; 1994 Feb; 12(2):142-4. PubMed ID: 8147096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge.
    Lulla V; Losada A; Lecollinet S; Kerviel A; Lilin T; Sailleau C; Beck C; Zientara S; Roy P
    Vaccine; 2017 Jul; 35(33):4262-4269. PubMed ID: 28625521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants.
    van Rijn PA; Maris-Veldhuis MA; Grobler M; Wright IM; Erasmus BJ; Maartens LH; Potgieter CA
    Vaccine; 2020 Oct; 38(45):7108-7117. PubMed ID: 32921506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness.
    van Rijn PA; Maris-Veldhuis MA; Boonstra J; van Gennip RGP
    Vaccine; 2018 Jun; 36(25):3584-3592. PubMed ID: 29759377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An attempt to define the host range for African horse sickness virus (Orbivirus, Reoviridae) in east Africa, by a serological survey in some Equidae, Camelidae, Loxodontidae and Carnivore.
    Binepal VS; Wariru BN; Davies FG; Soi R; Olubayo R
    Vet Microbiol; 1992 Apr; 31(1):19-23. PubMed ID: 1615634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus.
    Kanai Y; van Rijn PA; Maris-Veldhuis M; Kaname Y; Athmaram TN; Roy P
    Vaccine; 2014 Sep; 32(39):4932-7. PubMed ID: 25045805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.